Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2006 Abstracts: Is the Very Long Limb Roux-en-Y Gastric Bypass effective for patients with BMI > 60 kg/m2? An analysis of long-term follow-up in a cohort of 118 patients
Back to 2006 Program and Abstracts
Is the Very Long Limb Roux-en-Y Gastric Bypass effective for patients with BMI > 60 kg/m2? An analysis of long-term follow-up in a cohort of 118 patients
Taghreed Almahmeed, Tracy Torrella, Ali Kandil, Rodrigo Gonzalez, Malene Ingram, Scott F. Gallagher, Michel M. Murr; Surgery, University of South Florida, College of Medicine, Tampa, FL

INTRODUCTION: We have utilized the Very-Long limb Roux-en-Y Gastric Bypass (VLRYGB) which involves anastomosing the biliopancreatic limb to the ileum 100 cm proximal to the ileocecal valve, in the treatment of super-obese patients. The aim of this study is to evaluate the outcomes of VLRYGB in the treatment of patients whose BMI >60 kg/m2. METHODS: Prospectively collected data in all 118 consecutive patients with BMI≥60 Kg/m2 who underwent VLRYGB for the treatment of clinically significant obesity from 1998 - 2005 were analyzed. Patients' clinical characteristics, comorbidities, weight loss and complications were reviewed. Follow-up was from clinic visits and phone interviews. Data are mean ± SEM. RESULTS: 83 women and 35 men who underwent VLRYGB (age: 43±1 year; pre-operative BMI: 69±1 kg/m2) had the following major comorbidities: obstructive sleep apnea (64%), hypertension (61%), diabetes (32%) and venous thrombotic events (3%). Mean length of hospital stay was 6±1 days. Complications included: anastomotic leak (4%), gastrointestinal bleeding (3%), venous thrombotic events (3%), myocardial infarction (3%), sepsis (2%), anastomotic ulcer (1%), primary respiratory failure (1%), and renal failure (1%). In-hospital mortality was 3% and was mainly from anastomotic leaks and primary respiratory failure; 30 day mortality was 4%. Within one year post-operatively, 5 patients (4%) developed protein-calorie malnutrition which was reversed with enteral and parenteral protein supplements in 3 patients and by lengthening of the common channel in one patient; one patient who refused intervention died from subsequent liver failure. Overall follow-up was 30±2 months and is complete in 80% of patients. %Excess body weight loss (%EBWL) peaked at 2 years (66±2%, 95% confidence interval (CI): 63-70%) and was sustained at 5 years (66±4%, 95% CI: 58-74%) with 80% of patients achieving >50% EBWL. 95% of patients reported improvement in quality of life, diabetes, hypertension and/or obstructive sleep apnea. CONCLUSION: VLRYGB is effective in inducing durable and sustainable weight loss in super-obese patients that is associated with resolution of obesity-related comorbidities and improvement in quality of life. Close post-operative monitoring may reduce in-hospital mortality. Strict monitoring of nutritional indices is imperative to avoid long-term consequences of protein calorie malnutrition.


Back to 2006 Program and Abstracts


Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards